Rouen Cedex

May 14, 2024 | europeanurology.com | Marcus J. Drake |Christian Gratzke |Kari A.O. Tikkinen |Rouen Cedex

Abstract Symptomatic benefit and urodynamic obstruction relief represent relevant outcomes of therapies for lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). We summarized evidence from studies concurrently assessing variations in terms of symptoms severity and invasive urodynamic measures of obstruction following medical and surgical therapies for LUTS/BPH. We performed a systematic review of PubMed, Scopus, and Web of Science in June 2023.